LGHT vs. HRTS ETF Comparison
Comparison of Langar Global HealthTech ETF (LGHT) to Tema Cardiovascular and Metabolic ETF (HRTS)
LGHT
Langar Global HealthTech ETF
LGHT Description
LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.
Grade (RS Rating)
Last Trade
$10.25
Average Daily Volume
820
31
HRTS
Tema Cardiovascular and Metabolic ETF
HRTS Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.Grade (RS Rating)
Last Trade
$30.49
Average Daily Volume
14,989
36
Performance
Period | LGHT | HRTS |
---|---|---|
30 Days | -4.07% | -11.55% |
60 Days | -3.03% | -12.08% |
90 Days | -1.92% | -13.08% |
12 Months |
LGHT Overweight 28 Positions Relative to HRTS
Symbol | Grade | Weight | |
---|---|---|---|
ISRG | A | 15.39% | |
GEHC | D | 8.56% | |
RMD | C | 6.71% | |
IQV | F | 6.34% | |
VEEV | C | 5.15% | |
PHG | F | 4.87% | |
ZBH | C | 3.57% | |
BNTX | C | 3.53% | |
ALGN | D | 2.85% | |
DOCS | C | 2.06% | |
MRNA | F | 1.72% | |
PRCT | B | 1.27% | |
ALKS | C | 0.66% | |
TNDM | F | 0.54% | |
IRTC | C | 0.44% | |
PRVA | C | 0.44% | |
OMCL | C | 0.42% | |
LFST | C | 0.31% | |
TDOC | D | 0.28% | |
PGNY | F | 0.25% | |
EVH | F | 0.22% | |
SDGR | C | 0.21% | |
GDRX | F | 0.2% | |
ALHC | C | 0.2% | |
PHR | F | 0.17% | |
ACCD | F | 0.07% | |
MODV | D | 0.03% | |
TBRG | A | 0.03% |
LGHT Underweight 33 Positions Relative to HRTS
Symbol | Grade | Weight | |
---|---|---|---|
LLY | F | -6.44% | |
VRTX | D | -5.64% | |
AMGN | D | -5.11% | |
ALNY | D | -4.95% | |
CRNX | C | -4.0% | |
BBIO | F | -3.69% | |
CYTK | D | -3.47% | |
BSX | A | -2.99% | |
ASND | F | -2.88% | |
MDT | D | -2.79% | |
MIRM | C | -2.6% | |
MREO | F | -2.49% | |
IONS | F | -2.42% | |
REGN | F | -2.37% | |
KROS | D | -2.1% | |
EW | C | -1.91% | |
MLYS | D | -1.89% | |
RCKT | F | -1.8% | |
ARWR | D | -1.76% | |
RARE | F | -1.71% | |
NTLA | F | -1.66% | |
MDGL | C | -1.46% | |
WST | D | -1.43% | |
AKRO | C | -1.28% | |
NVS | D | -1.26% | |
VKTX | F | -1.14% | |
NARI | C | -0.97% | |
EWTX | C | -0.96% | |
SLN | F | -0.91% | |
TERN | F | -0.7% | |
VERV | D | -0.64% | |
TNYA | C | -0.43% | |
RANI | D | -0.31% |
LGHT: Top Represented Industries & Keywords
HRTS: Top Represented Industries & Keywords